Atai Life Sciences Price to Sales Ratio 2020-2023 | ATAI
Historical PS ratio values for Atai Life Sciences (ATAI) over the last 10 years. The current P/S ratio for Atai Life Sciences as of April 24, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Atai Life Sciences P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-24 | 1.87 | 961.53 | |
| 2023-12-31 | 1.41 | $0.00 | 0.00 |
| 2023-09-30 | 1.29 | $0.00 | 0.00 |
| 2023-06-30 | 1.72 | $0.00 | 0.00 |
| 2023-03-31 | 1.81 | $0.00 | 0.00 |
| 2022-12-31 | 2.66 | $0.00 | 0.00 |
| 2022-09-30 | 3.31 | $0.00 | 0.00 |
| 2022-06-30 | 3.64 | $0.00 | 0.00 |
| 2022-03-31 | 5.09 | $0.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.330B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.733B | 10.12 |
| Quest Diagnostics (DGX) | United States | $15.181B | 15.69 |
| DaVita (DVA) | United States | $11.744B | 15.98 |
| Chemed (CHE) | United States | $9.320B | 29.33 |
| Encompass Health (EHC) | United States | $8.258B | 22.65 |
| Elanco Animal Health (ELAN) | United States | $6.651B | 15.12 |
| Option Care Health (OPCH) | United States | $5.317B | 20.12 |
| RadNet (RDNT) | United States | $3.344B | 97.66 |
| Amedisys (AMED) | United States | $2.978B | 21.25 |
| LifeStance Health (LFST) | United States | $2.326B | 0.00 |
| Astrana Health (ASTH) | United States | $2.077B | 26.21 |
| U.S Physical Therapy (USPH) | United States | $1.558B | 40.39 |
| Addus HomeCare (ADUS) | United States | $1.538B | 23.57 |
| Pennant (PNTG) | United States | $0.643B | 37.58 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.437B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.017B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |